Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.
Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a healthcare stock. It opens up new growth opportunities for the business.
Vertex AI is a natural language understanding ... The revamped product now also supports AMD GPUs and Nvidia NIM. Cranium AI Exposure Management Startup Cranium AI is focused on securing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results